MedPath

Prospective observational study of the treatment and prognosis in patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.

Not Applicable
Conditions
Adult T-cell leukemia-lymphoma
Registration Number
JPRN-UMIN000009251
Lead Sponsor
JSCT
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

No

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall Survivalat 1 year after relapse
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath